首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
Apixaban/rivaroxabanBleeding: 3 case reports
被引:0
|
作者
:
机构
:
来源
:
Reactions Weekly
|
2019年
/ 1744卷
/ 1期
关键词
:
D O I
:
10.1007/s40278-019-58950-z
中图分类号
:
学科分类号
:
摘要
:
引用
下载
收藏
页码:51 / 51
相关论文
共 50 条
[31]
Apixaban/aspirin/clopidogrelEpistaxis, melaena and haematuria: 3 case reports
Reactions Weekly,
2025,
2048
(1)
: 51
-
51
[32]
Apixaban/dabigatran etexilate/rivaroxabanHaemorrhagic complications: 3 case reports
Reactions Weekly,
2019,
1738
(1)
: 45
-
45
[33]
Apixaban/warfarinBleeding : 2 case reports
Reactions Weekly,
2022,
1905
(1)
: 88
-
88
[34]
Apixaban/edoxabanHaemorrhage: 9 case reports
Reactions Weekly,
2019,
1749
(1)
: 64
-
64
[35]
Apixaban/warfarinBleeding : 2 case reports
Reactions Weekly,
2022,
1910
(1)
: 79
-
79
[36]
RivaroxabanBleeding: case report
Reactions Weekly,
2018,
1725
(1)
: 260
-
260
[37]
Apixaban/rivaroxabanLack of efficacy and non major bleeding: 3 case reports
Reactions Weekly,
2022,
1889
(1)
: 59
-
59
[38]
Apixaban/dabigatran etexilate/rivaroxabanGastrointestinal haemorrhage and anaemia: 3 case reports
Reactions Weekly,
2019,
1751
(1)
: 50
-
50
[39]
Apixaban/dabigatran-etexilate/rivaroxabanExcessive bleeding : 3 case reports
Reactions Weekly,
2022,
1920
(1)
: 80
-
80
[40]
Apixaban/heparin/warfarinBleeding and drop in haemoglobin level: 3 case reports
Reactions Weekly,
2018,
1711
(1)
: 35
-
35
←
1
2
3
4
5
→